Good luck and GOD bless,
Go CTIX!
I agree with George, Kevetrin will be a game changer but it is several years out.
many combo trials await and lets not forget Bologna
Oh, by the way, why hasn't that trial started yet ?
Maybe Leo will update us at R and R in NYC
20 days left till conference updates
CTIX Stock Message Board http://investorshangout.com/Cellceutix-Corpor...TIX-87375/
Yawwwn. Not again. This horse is dead. George did you miss a chance to average down. Come on let's move along. It's been a good day for Pete's sake. Can we give it a days rest
As I have said before do not expect miracles for Kevetrin.
I do however that Kevetrin will be a blockbuster drug as an diction to standard chemotherapy and/or radiation therapy.
I hope that EllaRuth is right, but I doubt it.
Good luck and GOD bless,
George
Miles, hang in there. Charts nor anyone can tell you when a stock will be quadruple swing term then more. Sound familiar? Long over 100k on that one and done for the year? Not by a long shot. In fact, long again in that one and you know the share count. The secret is the best stock now hopefully at the right time. And if the timing is off, you're best stock now will still save in the end. Don't allow the short term TA mumbo jumbo to distort. Use the reading I did to temp sell like on our other one, it's the best there is and I posted it real time. No worries my friend and Shalom......................
Patience.......the art of concealing ones impatience. Our patience will be rewarded in time. We have breathed this $2 air before, but it smells sweeter this time, knowing good news on all fronts and trial escalation is eminent. SP dilution by Aspire selling is disconcerting, yes....but is still necessary. Three solid days consecutively. Yeah baby, I'll take that. Go CTIX and Go Gamecocks!!!! Kickoff is only 8 days away.
Well then, I suppose you must be one of the posters who "carefully read the PRs, know the industry or the science, show the patience of an experienced investor, and disregard those irrelevant posts."
Otherwise...?
For what it's worth, there are a number of posters who don't have access to real time bid and ask and appreciate knowing what's going on when things are hot.
Go Miles! I agree the big wall at $2.00 seemed so desperate and obvious there must be a reason beyond traders seeing the RSI top out. Ridiculous. Someone got caught short and is trying to cap it. This started over a week ago.
Go CTIX!
I have to admit, I ignore "TA" posts. Same with posts about the bid/ask, guessing the close, complaining about "greedy MM's trying to steal shares", etc. The only useful thing about those posts is they help me identify the posters whose opinions I shouldn't put as much weight on.
The folks who carefully read the PRs, know the industry or the science, show the patience of an experienced investor, and disregard those irrelevant posts, they're the ones worth reading and are why I'm here.
Thank you sir, the rat in my brain that was doing all the gnawing has been euthanized. I will no longer have to wake up at 4am worrying about P.
Checking in ! I told you GREAT things happen on my Birthday ! Life and GOD is GOOD and LEO is GOOD as well ! And Dr. Menon and his Chemistry Knowledge and TINKERING is COMPELLING ! Keep the FAITH Pals ! BTW....I took care of that " Twinkle " and had a wonderful day ! : )
GO CTIX !
Jok, I had same question on Prurisol/abacavir a few weeks ago and got helpful answers, search my posts
I know that what i see in the rat slides, if it works that well in humans, it will blow the roof off of psoriasis treatment.
Thanks
Can someone kindly explain to me the difference between prurisol and Ziagen (Abacavir) ? If prurisol converts to Abacavir once it enters the body why isn't Ziagen used to treat Psorisis. I know that Ziagen is used to treat HIV. Could prurisol be used for the same? This has been gnawing at my brain for a while.
Thanks JOK
I hope you are right.
I like TA as much as the next guy...
NR is my favorite chartist on ANY board and I respect him immensely, which is why the following is so difficult to say:
You are wrong. How do I know? Because I just typed that.
Witness the 60k+ wall thrown up at $2.00.
Desperation is a stinky cologne.
They can't keep a lid on this. Not at this pace.
Some person or persons is more than happy to gobble at 2.00 ALL day long. There is a finite number of shares at $2 and it seems to be fairly thin after that.
Yes, yes, I know what RSI says. Have you never witnessed a sustained move with RSI pegged? I have.
We've been coiled for so long, with so many catalysts brewing, now coming to fruition, that at some point, charts just don't explain it any longer.
Did the charts predict six figure volume three trading days in a row, and now approaching seven figs?
I think we continue running with any pullbacks being very minor.
Another high volume day tomorrow with a solid push and hold over $2 and we will never see sub $2 again.
I love your posts and charts and will continue to do so.
This is simply my feelings on the matter and more or less mean nothing. I will toot my own horn a bit and point out that I did call for $2 this week while most were saying one or two weeks.
Ready to suit up.
Let me have it.
That's right around the area I was thinking too BigK. But that's just the beginning. Around $300 - $650m per quarter sales is a good slice of the pie imo. I'm not one to get ahead of myself though. But a $4 - $8 pps market cap somewhere during phase 2/3 isn't out of the question. Then with something solid comes the uplisting.
Quote:
Considering market, B-ABSSSI license alone is worth $350 million to $500 million ($700 million is within range but a little on the high side IMO), including $35 million to $100 million upfront.
We now have 6 other 1/2 billion to billion dollar indications/formulations for B:
Brilacidin-OM
Brilacidin-Ocular
Brilacidin-Otic
Gram Negative Bacteria
Candidiasis
Diabetic Foot Infections/Ulcers
That's a lot of Phase 2/3 trials to move, so it would be very nice to license ABSSSI and pay for everything else, including K and P.
Just my own WAG.
I don't think it is realistic to expect that...I hope you are right, but I can't see it, not even down the road a ways.
$700 million would be my estimate for B, period, all indications, given a favorable p2b. I don't think that is too low at this point. Others do, and that is okay. After p3 and the trials for the other indications, 2 billion or so. So is it worth the wait and the additional dilution? What is the risk of B not doing so well v. other indications?